399 related articles for article (PubMed ID: 9400508)
1. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration.
Lancet; 1997 Dec; 350(9092):1647-54. PubMed ID: 9400508
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Sarcoma Meta-analysis Collaboration (SMAC).
Sarcoma Meta‐analysis Collaboration (SMAC) ‐ see acknowledgement section for list of authors
Cochrane Database Syst Rev; 2000; 2000(2):CD001419. PubMed ID: 10796873
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults.
Sarcoma Meta-analysis Collaboration (SMAC)
Cochrane Database Syst Rev; 2000; (4):CD001419. PubMed ID: 11034717
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
Woll PJ; Reichardt P; Le Cesne A; Bonvalot S; Azzarelli A; Hoekstra HJ; Leahy M; Van Coevorden F; Verweij J; Hogendoorn PC; Ouali M; Marreaud S; Bramwell VH; Hohenberger P;
Lancet Oncol; 2012 Oct; 13(10):1045-54. PubMed ID: 22954508
[TBL] [Abstract][Full Text] [Related]
5. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma.
Pervaiz N; Colterjohn N; Farrokhyar F; Tozer R; Figueredo A; Ghert M
Cancer; 2008 Aug; 113(3):573-81. PubMed ID: 18521899
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant chemotherapy in soft tissue sarcoma: review and meta-analysis of published data of randomized clinical trials].
Budach V
Strahlenther Onkol; 1996 Jul; 172(7):403-4. PubMed ID: 8693407
[No Abstract] [Full Text] [Related]
7. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
[TBL] [Abstract][Full Text] [Related]
8. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
[TBL] [Abstract][Full Text] [Related]
10. Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall.
Jebsen NL; Bruland ØS; Eriksson M; Engellau J; Turesson I; Folin A; Trovik CS; Hall KS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1359-66. PubMed ID: 20933339
[TBL] [Abstract][Full Text] [Related]
11. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
12. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
Schuetze SM; Patel S
Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770
[TBL] [Abstract][Full Text] [Related]
13. [Role of adjuvant chemotherapy in the treatment of soft tissue sarcoma].
Debled M; Ravaud A; Stöckle E; Nguyen BB
Bull Cancer; 1997 Jun; 84(6):653-63. PubMed ID: 9295870
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas.
Mullen JT; Kobayashi W; Wang JJ; Harmon DC; Choy E; Hornicek FJ; Rosenberg AE; Chen YL; Spiro IJ; DeLaney TF
Cancer; 2012 Aug; 118(15):3758-65. PubMed ID: 22180344
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy of sarcomas of soft tissue.
Antman KH
Semin Oncol; 1997 Oct; 24(5):556-60. PubMed ID: 9344322
[TBL] [Abstract][Full Text] [Related]
16. Current trials and new aspects in soft tissue sarcoma of adults.
Issels RD; Schlemmer M
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy for soft tissue sarcomas.
Mertens WC; Bramwell VH
Hematol Oncol Clin North Am; 1995 Aug; 9(4):801-15. PubMed ID: 7490242
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-cisplatin chemotherapy for high-grade nonosteogenic sarcoma of bone. Comparison of treatment and control groups.
Waddell AE; Davis AM; Ahn H; Wunder JS; Blackstein ME; Bell RS
Can J Surg; 1999 Jun; 42(3):190-9. PubMed ID: 10372015
[TBL] [Abstract][Full Text] [Related]
19. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes.
Cormier JN; Huang X; Xing Y; Thall PF; Wang X; Benjamin RS; Pollock RE; Antonescu CR; Maki RG; Brennan MF; Pisters PW
J Clin Oncol; 2004 Nov; 22(22):4567-74. PubMed ID: 15542808
[TBL] [Abstract][Full Text] [Related]
20. Feasibility study of postoperative adjuvant chemotherapy and radiotherapy for soft-tissue sarcoma.
Fuchs R; Schadeck-Gressel C; Makoski HB; von Andrian-Werburg HF; Knieriem HJ; Westerhausen M
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S199-203. PubMed ID: 8453698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
